-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Thymalfasin in Thymic Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Thymalfasin in Thymic Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thymalfasin in Thymic Carcinoma Drug Details: Thymalfasin (Zadaxin) is a synthetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Prp in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Prp in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.PRP in Melanoma Drug Details:PRP is under development for the treatment of solid tumors...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – tegoprazan
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry tegoprazan Drug Details Tegoprazan (RQ-00000004, CJ-12420) is a benzimidazole derivative acts as antiulcer agent....
-
Sector Analysis
Contraceptives: Opportunity Analysis and Forecasts to 2027
Hormonal contraceptives are primarily used to prevent unintended pregnancy; however, some of these contraceptives are also approved or used off-label for other health conditions, particularly menstrual-related disorders. This report focuses on female hormonal contraceptives used for birth control as well as other non-contraceptive benefits distinct from their ability to prevent pregnancy. Female hormonal contraceptives are used in women of reproductive age, which according to the World Health Organization (WHO) refers to all women ages 15–49 years. GlobalData estimates the 2017...
-
Product Insights
Constipation Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H1, 2019" provides an overview of Constipation clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
PharmaPoint: Irritable Bowel Syndrome(IBS) – Global Drug Forecast and Market Analysis to 2026
Irritable bowel syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered bowel function. IBS is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least three months. IBS is classified into three main subtypes, according to the predominant bowel habit: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), and mixed-presentation (IBS-M) IBS. The IBS treatment landscape remains largely underserved, and ample opportunity exists for pharmaceutical companies to address the...
-
Product Insights
Constipation Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H1, 2020" provides an overview of Constipation Clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...